Two of the most talked-about names in the probiotic space are Med-Lock and Pendulum. But while both offer microbiome-focused formulations, their strategies couldn’t be more different. Here's what makes them distinct—and how to know which one might be right for you.

Overview
- Med-Lock’s DS-01® Daily Synbiotic is designed for systemic benefits, including digestive, gut barrier, cardiovascular, dermatological, and micronutrient synthesis support. Pendulum Therapeutics offers targeted probiotic formulations, like Glucose Control and Akkermansia.
- Med-Lock’s DS-01® features 24 clinically studied probiotic strains from Lactobacillus and Bifidobacterium genera. Pendulum typically uses novel anaerobic strains, like A. muciniphila, Clostridium species, and A. hallii.
- DS-01® includes a non-fermenting polyphenol-based prebiotic (MAPP™ from Indian pomegranate). Pendulum products often use fermentable fibers like chicory inulin or oligofructose.
- DS-01® uses ViaCap® delivery technology and measures potency in AFU (Active Fluorescent Units) for precision. Pendulum also uses AFU and employs delayed-release capsules; some products require refrigeration.
- Med-Lock prioritizes human clinical trials and research for its multi-strain formulation. Pendulum often targets specific conditions with novel strains, conducting clinical research for those indications.
Choosing a probiotic can feel like sorting through too many confusing names and lofty health claims. You’re trying to find something that supports your system, but with so many formulas claiming to be “the one,” it’s easy to get stuck. 🧠 Two standouts in the microbiome space? Med-Lock’s DS-01® Daily Synbiotic and Pendulum Therapeutics.
They’re both rooted in science, but their strategies are very different. One is built for daily, whole-body support; the other zeroes in on specific targets, like blood sugar or gut lining strength.
If you’re weighing your options, this guide breaks it down: what’s inside, how they work, what science supports them, and which might align better with your health goals.
What Type of Products Are We Looking At?
Synbiotic vs. Targeted Probiotic
Med-Lock’s DS-01® is a synbiotic—a product that combines probiotics (beneficial microbes) with a prebiotic (a compound that supports those microbes). It’s formulated to impact multiple body systems, from digestive and immune health to cardiovascular and skin health.
Pendulum offers targeted probiotics, sometimes with prebiotics, focused on specific conditions. These include products like Pendulum Glucose Control or Pendulum Akkermansia.
👉 TL;DR: DS-01® is built for broad, daily support, while Pendulum leans specialized.
Key Differences at a Glance
| Feature | Med-Lock’s DS-01® Daily Synbiotic | Pendulum Therapeutics (Glucose Control) | Pendulum Therapeutics (Akkermansia) |
|---|---|---|---|
| Product Category | Broad-spectrum Synbiotic (Probiotic + Prebiotic) | Targeted Probiotic ( Synbiotic) | Targeted Probiotic (Synbiotic) |
| Probiotic Strains | 24 diverse strains (Lactobacillus & Bifidobacterium genera) | 5 anaerobic/facultative strains (from genera: Akkermansia, Clostridium, Anaerobutyricum, Bifidobacterium) | 1 anaerobic strain (A. muciniphila) |
| Total Potency | 53.6 Billion AFU | 2 Billion AFU | 100 Million AFU |
| Potency Measurement | AFU (Active Fluorescent Units) | AFU (Active Fluorescent Units) | AFU (Active Fluorescent Units) |
| Key Benefits | Digestive health, gut barrier, gut immune function, cardiovascular health, dermatological health, micronutrient synthesis | May lower A1C & blood glucose spikes | Fortifies gut lining, reduces gut permeability, supports overall gut health |
| Prebiotic Type | MAPP™ (Polyphenol-based from Indian Pomegranate, non-fermenting) | Oligofructose and chicory inulin (fermentable fibers) | Chicory Inulin (fermentable fiber) |
| Postbiotic Component | No direct added postbiotics; focuses on microbial metabolite production via prebiotics | No direct added postbiotics; focuses on butyrate production by strains | No direct added postbiotics |
| Delivery Technology | ViaCap® (2-in-1 nested capsule, precision release, no refrigeration needed) | Plant-based, acid-resistant, delayed-release capsule; Refrigeration required | Plant-based, acid-resistant, delayed-release capsule; Refrigeration recommended but not required |
| Scientific Research Focus | Broad systemic health in adult populations; specific strain benefits backed by multiple studies | Targeted conditions; novel anaerobic strains | Gut barrier function; novel anaerobic strain |
| Price (per 30-day supply) | $49.99 | $99 (subscription) / $159 (one-time) | $42 (subscription) / $67 (one-time) |
A Closer Look: Med-Lock’s DS-01® Daily Synbiotic
Med-Lock’s DS-01® Daily Synbiotic isn’t just a capsule—it’s a scientifically-crafted ecosystem that pairs 24 clinically studied probiotic strains with a novel polyphenol-based prebiotic. Think of it as a microbial support system that’s been fine-tuned for whole-body health. 🧠
Strain Diversity That Actually Means Something
You’ve probably seen “billions of probiotics” on labels before, but what really matters is the exact strains inside. DS-01® includes 24 distinct strains from the Lactobacillus and Bifidobacterium genera, each carefully selected for its specific action and studied benefits. It’s not just species that matter—it’s strain designations, like B. longum BB536 or L. plantarum LPLDL. That’s where the science lives.
Choosing a probiotic without strain info is like hiring someone named “John” for a job without knowing whether they’re an accountant or a plumber. Strain specificity is the difference between guesswork and targeted support.
DS-01® is formulated for more than just digestive support. Each included strain was chosen for its documented ability to support specific areas of health, and Med-Lock is transparent about these claims, linking them to published studies:
- Digestive Health: Can support healthy regularity, eases occasional bloating, and promotes stool hydration and comfort.7,8
- Gut Barrier Integrity: Certain strains in DS-01® may support the function of tight junctions—those tiny gatekeepers that help maintain a strong gut lining.2
- Gut Immune Function: Promotes healthy communication between gut microbes and immune cells, and supports short-chain fatty acid production.9
- Cardiovascular Health: Helps maintain cholesterol levels already within a normal range and supports bile recycling.10
- Dermatological Health: Supports the gut-skin axis by promoting a balanced microbial environment that reflects in skin clarity.11
- Micronutrient Synthesis: Supports folate (vitamin B9) production and contributes to vitamin B12 synthesis in vitro.12,13
💡 Pro Tip: Look for strain-level science when evaluating any probiotic, because the benefits are linked to the microbe, not just the name.
Backed by Human Trials
DS-01® isn’t just assembled from clinically studied strains—it’s been studied as a full formulation. In two randomized, double-blind, placebo-controlled trials, DS-01® was tested on people with occasional GI disruptions. Results showed enrichment of beneficial bacteria, improved bowel regularity, and support for gut barrier function.
Understanding Potency: AFU vs. CFU
You’ve probably seen CFU on probiotic labels—short for Colony Forming Units. It’s the old-school method of estimating how many bacteria are alive and able to grow on a lab dish. But here’s the catch: some beneficial bacteria just don’t like lab settings. They’re alive, but they won’t “form colonies,” so they don’t get counted.
That’s where AFU (Active Fluorescent Units) comes in. Med-Lock uses AFU, measured via flow cytometry—basically a laser-based cell scanner that tags and counts every viable cell, including the ones that wouldn’t show up in a CFU test. Picture CFU as a roll call where only loud extroverts respond. AFU is a headcount that includes everyone, even the introverts.
This method gives a clearer picture of what’s actually alive and active in each dose. DS-01® delivers 53.6 Billion AFU, so you’re getting a precise, science-backed measure of microbial viability. 🔬
The Prebiotic Partner: MAPP™ Technology
DS-01® doesn’t just bring probiotics to the party—it brings a thoughtfully designed prebiotic to support them, too. Med-Lock’s Microbiota-Accessible Polyphenolic Precursors™ (MAPP™) are derived from Indian pomegranate (whole fruit) and don’t behave like traditional fiber-based prebiotics.
Instead of fermenting and potentially causing gas, these polyphenols are biotransformed (chemically converted by gut bacteria) into beneficial compounds like urolithins. It’s less about overfeeding microbes and more about giving them raw materials to produce helpful metabolites. Think of it like stocking a kitchen with ingredients, not just snacks. The result? Support that extends beyond your gut.
The Delivery System: ViaCap® Technology
Surviving the stomach’s acidic conditions is no small feat for probiotics. DS-01® uses ViaCap®, a capsule-in-capsule delivery system engineered to get the microbes where they need to go—your colon.
Here’s how it works: the outer capsule holds the prebiotic, while the inner capsule houses the probiotics. It’s like a two-stage rocket, with the outer layer shielding the inner payload through the harsh upper digestive tract. This design helps preserve viability without the need for refrigeration, and makes DS-01® both travel-friendly and gut-smart.
Conscious Packaging: Med-Lock’s Approach to Sustainability
Med-Lock’s commitment to care goes beyond the gut. DS-01® arrives in a Welcome Kit that includes a refillable glass jar and travel vial—designed for long-term use, not landfill. Monthly refills are packaged in compostable bio-based pouches, and everything ships in FSC-certified boxes with bio-based protective trays.
In other words: you’re not just supporting your microbes—you’re avoiding single-use plastic, too. It’s a small but meaningful step toward sustainability, one dose at a time. 🌎
Scientific Foundation: Research and Testing
Med-Lock doesn’t stop at strain selection. DS-01® is built on a foundation of rigorous science, at every level:
- Strain Validation: Each of the 24 strains was chosen based on clinical and preclinical data that support its specific mechanism and benefit.
- Finished Product Trials: DS-01® has been tested as a complete formulation in double-blind, randomized, placebo-controlled trials (not just pieced together from existing strain research).
- Comprehensive Testing: Every batch undergoes third-party testing for AFU potency through expiry, purity (no heavy metals, pesticides, or common allergens), and survivability, ensuring that ViaCap® delivers the goods where they count.
Science isn’t just a selling point here, it’s the framework. DS-01® is built to meet the highest standards of precision, transparency, and efficacy.
A Closer Look: Pendulum Therapeutics
Pendulum Therapeutics has carved a unique path in the probiotic world by focusing on targeted formulations with novel anaerobic strains, especially those tied to metabolic health. Instead of offering general probiotic support, Pendulum zeroes in on specific functions like blood sugar management or gut lining reinforcement.
Meet the Microbes: Anaerobic and Specialized
Pendulum’s formulations are known for including anaerobic bacteria—strains that thrive in the oxygen-free zones of your large intestine. These aren’t your average yogurt microbes. Some standout species include:
- Akkermansia muciniphila: A “keystone species” for the gut lining, this bacterium breaks down mucin and is linked to gut barrier integrity and metabolic support.1 Pendulum uses their proprietary strain, A. muciniphila WB-STR-0001.
- Clostridium butyricum & Clostridium beijerinckii: Known butyrate producers—short-chain fatty acids (fuel for your gut lining) that help nourish colon cells.
- Anaerobutyricum hallii: Another butyrate-supporting strain, often used alongside Clostridium species. 5
- Bifidobacterium infantis: More familiar, but still used in Pendulum blends for its potential role in butyrate pathways and general gut support.
Example formulations include Pendulum Akkermansia, which contains 100 million AFU of A. muciniphila, and Pendulum Glucose Control, which includes a five-strain blend totaling 2 billion AFU, formulated specifically for nutritional support.
The Prebiotic Angle: Fermentable Fibers
Pendulum takes a traditional fiber-first approach to prebiotics. Most of their products include chicory inulin and/or oligofructose—fermentable fibers that act as microbial fuel. Pendulum Akkermansia, for example, includes chicory inulin, while Pendulum Glucose Control includes both chicory inulin and oligofructose.
These fibers feed targeted microbes and help promote butyrate production, which supports gut barrier function and metabolic health.3,6
That said, fermentable fibers aren’t always the best fit for everyone. If you’re sensitive to FODMAPs (types of fermentable carbohydrates), you might notice mild side effects like bloating or gas as your gut adjusts.
What Else Is Inside?
Pendulum tends to keep things streamlined: probiotics, prebiotics, and that’s about it. They do offer an add-on Polyphenol Booster as a separate product, but their core formulations stay focused.
What Pendulum Claims—and What the Science Says
Pendulum aligns its claims with each product’s purpose. Their best-known product, Pendulum Glucose Control, is aimed at people with certain conditions, and is supported by human clinical research. Meanwhile, Pendulum Akkermansia is more exploratory, focused on growing levels of a single microbe that’s gaining scientific attention.
Pendulum Glucose Control
Designed as a medical probiotic for those with diagnosed conditions, often alongside metformin, claims include reducing A1C by .6, lower post-meal glucose spikes by 32.5%, supporting gut barrier integrity, and producing butyrate and increasing GLP-1 (a hormone that supports blood sugar control)
These claims are backed by a placebo-controlled clinical trial.4
Pendulum Akkermansia
Designed for gut lining support by increasing levels of A. muciniphila, claims include helping reinforce the mucin layer of the gut, and potentially reducing cravings through a possible gut-brain signaling effect. It’s worth noting that current evidence is largely preclinical, with additional consumer-reported data
Survivability and Storage: What You Should Know
To help their strains survive digestion, Pendulum uses plant-based, acid-resistant, delayed-release capsules. They’re built to shield microbes from stomach acid and release them farther down in the digestive tract.
That said, some products—like Glucose Control—require refrigeration. Others, like Akkermansia, suggest refrigeration if possible but say room-temperature storage is okay short-term. That might be a factor for you if portability or travel-friendliness matters.
Pendulum’s use of anaerobic strains like A. muciniphila is exciting, especially as science continues to explore their links to metabolic health. But it’s still early days. These strains haven’t been studied as extensively as longtime staples like Lactobacillus or Bifidobacterium.
That doesn’t mean they aren’t promising—it just means you’re entering less-charted territory. If you’re considering Pendulum, especially for a diagnosed condition, it’s best to talk with your healthcare provider.
What Does This Mean For You? Choosing an Ally for Your Gut Health
Choosing between Med-Lock’s DS-01® and a Pendulum product comes down to what you’re looking to support, and how broadly or precisely you want to do it.
DS-01®: A Broad-Spectrum, Daily Support System
If your goal is to support digestive regularity, gut barrier function, immune communication, skin clarity, and more—from one well-researched formulation—DS-01® is designed for daily, whole-body support. With 24 clinically studied strains, a novel polyphenol-based prebiotic (MAPP™), and precision delivery via ViaCap®, it’s built to deliver consistent microbial impact without refrigeration.
It’s a smart choice for people seeking a daily routine that supports long-term health across multiple systems, not just one condition.
Pendulum: A Targeted Tool for Specific Needs
Pendulum takes a more focused approach. Its products are often intended for certain populations. Pendulum Glucose Control is designed for people with specific conditions diagnosed by a medical professional and is backed by a clinical trial showing its effect on A1C and post-meal glucose spikes, particularly alongside metformin.
Pendulum Akkermansia is for people aiming to increase levels of A. muciniphila, a strain associated with gut lining integrity and potential appetite signaling.
These formulations are narrower in scope, but potentially valuable for those with targeted needs or under medical supervision.
Science in Different Phases
DS-01® is backed by extensive clinical, mechanistic, and product-specific research. It also focuses on strains with long-established safety and efficacy profiles. Pendulum’s work with anaerobic probiotics like Akkermansia is exciting and pioneering, but the research is still early-stage for broad consumer application.
So, if you’re looking for trusted diversity with daily consistency, DS-01® delivers. If you’re managing a specific metabolic condition and working with your doctor, Pendulum may offer something more focused.
The Key Insight
Probiotic decisions aren’t one-size-fits-all—and “niche” doesn’t always mean “better.” It’s about finding what fits your biology and your goals.
Med-Lock’s DS-01® is built for systemic support—using 24 clinically studied strains, a polyphenol-based prebiotic, and advanced delivery technology to nurture multiple systems from the gut outward. It’s a daily synbiotic grounded in science and designed for whole-body consistency.
Pendulum’s offerings are narrower by design, targeting specific outcomes like blood sugar management or mucin layer support with novel anaerobic strains. These are compelling tools—but often best suited to condition-specific use and active clinical care.
Your gut isn’t a one-note system. So whether you’re building long-term resilience or targeting a single marker, look for solutions that match the science and your needs.
Good health isn’t hacked—it’s cultured. Choose a product that respects the science—and your biology. 🌱
Frequently Asked Questions (FAQs)
Is Pendulum Akkermansia the Same as Med-Lock’s DS-01®?
No—they serve different purposes. Pendulum Akkermansia is a single-strain probiotic focused on A. muciniphila, with chicory inulin as its prebiotic. DS-01® contains 24 strains from Lactobacillus and Bifidobacterium genera, plus a polyphenol-based prebiotic, offering broader systemic support beyond just the gut lining.
What Is Pendulum Glucose Control Primarily Used For?
It’s formulated for people with diagnosed conditions. Pendulum Glucose Control is a medical probiotic studied to help manage A1C and post-meal blood glucose spikes. It’s usually taken in conjunction with medications like metformin and is backed by a clinical trial.
Can DS-01® Help With Blood Sugar or Metabolic Health?
DS-01® is not formulated for blood sugar management. While a healthy gut microbiome may support general metabolic balance, DS-01® hasn’t been studied for A1C or glucose regulation like Pendulum Glucose Control. For targeted blood sugar support, Pendulum is the more direct option.
Which Is More Expensive: Med-Lock’s DS-01® or Pendulum?
Pendulum products tend to be more expensive. DS-01® costs $49.99 per 30-day supply. Pendulum Akkermansia ranges from $42-$67, while Glucose Control runs $99-$159, depending on subscription status.
Citations
- He, K., An, F., Zhang, H., Yan, D., Li, T., Wu, J., & Wu, R. (2024). Akkermansia muciniphila: A Potential Target for the Prevention of Diabetes. Foods, 14(1), 23. https://doi.org/10.3390/foods14010023
- Iemoli, E., Trabattoni, D., Parisotto, S., Borgonovo, L., Toscano, M., Rizzardini, G., Clerici, M., Ricci, E., Fusi, A., De Vecchi, E., Piconi, S., & Drago, L. (2012). Probiotics reduce gut microbial translocation and improve adult atopic dermatitis. Journal of Clinical Gastroenterology, 46, S33–S40. https://doi.org/10.1097/mcg.0b013e31826a8468
- Van Harsselaar, J., Mödinger, Y., Dharsono, T., Menzel, D., Theis, S., & Schön, C. (2024). Prebiotic effect of oligofructose after 2 weeks supplementation with a low dose: A randomized, double-blind, placebo-controlled, cross-over study. Journal of Functional Foods, 119, 106356. https://doi.org/10.1016/j.jff.2024.106356
- Perraudeau, F., McMurdie, P., Bullard, J., Cheng, A., Cutcliffe, C., Deo, A., Eid, J., Gines, J., Iyer, M., Justice, N., Loo, W. T., Nemchek, M., Schicklberger, M., Souza, M., Stoneburner, B., Tyagi, S., & Kolterman, O. (2020). Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation. BMJ Open Diabetes Research & Care, 8(1), e001319. https://doi.org/10.1136/bmjdrc-2020-001319
- Bunesova, V., Lacroix, C., & Schwab, C. (2017). Mucin Cross-Feeding of Infant Bifidobacteria and Eubacterium hallii. Microbial Ecology, 75(1), 228–238. https://doi.org/10.1007/s00248-017-1037-4
- Bastard, Q. L., Chapelet, G., Javaudin, F., Lepelletier, D., Batard, E., & Montassier, E. (2019). The effects of inulin on gut microbial composition: a systematic review of evidence from human studies. European Journal of Clinical Microbiology & Infectious Diseases, 39(3), 403–413. https://doi.org/10.1007/s10096-019-03721-w
- Del Piano, M., Carmagnola, S., Anderloni, A., Andorno, S., Ballarè, M., Balzarini, M., Montino, F., Orsello, M., Pagliarulo, M., Sartori, M., Tari, R., Sforza, F., & Capurso, L. (2010). The use of probiotics in healthy volunteers with evacuation disorders and hard stools. Journal of Clinical Gastroenterology, 44(Supplement 1), S30–S34. https://doi.org/10.1097/mcg.0b013e3181ee31c3
- Ogata, T., Nakamura, T., Anjitsu, K., Yaeshima, T., Takahashi, S., Fukuwatari, Y., Ishibashi, N., Hayasawa, H., Fujisawa, T., & Iino, H. (1997). Effect of Bifidobacterium longum BB536 Administration on the Intestinal Environment, Defecation Frequency and Fecal Characteristics of Human Volunteers. Bioscience and Microflora, 16(2), 53–58. https://doi.org/10.12938/bifidus1996.16.53
- Fong, F. L. Y., Kirjavainen, P. V., & El-Nezami, H. (2016). Immunomodulation of Lactobacillus rhamnosus GG (LGG)-derived soluble factors on antigen-presenting cells of healthy blood donors. Scientific Reports, 6(1). https://doi.org/10.1038/srep22845
- Costabile, A., et al. (2017). A novel bacterium, Lactobacillus plantarum LPLDL, with cholesterol-lowering and bile-salt-deconjugating activities. PLoS One, 12(12), e0189475. https://www.ncbi.nlm.nih.gov/pubmed/29228000
- Navarro-López, V., Ramírez-Boscá, A., Ramón-Vidal, D., Ruzafa-Costas, B., Genovés-Martínez, S., Chenoll-Cuadros, E., Carrión-Gutiérrez, M., De La Parte, J. H., Prieto-Merino, D., & Codoñer-Cortés, F. M. (2017). Effect of oral administration of a mixture of probiotic strains on SCORAD index and use of topical steroids in young patients with moderate atopic dermatitis. JAMA Dermatology, 154(1), 37. https://doi.org/10.1001/jamadermatol.2017.3647
- Strozzi, G. P., & Mogna, L. (2008). In vivo absorption of folate by Bifidobacterium adolescentis MB 239. Journal of Clinical Gastroenterology, 42 Suppl 3 Pt 2, S179-S180. https://www.ncbi.nlm.nih.gov/pubmed/18685499
- Bron, P. A., Catalayud, M., Marzorati, M., Pane, M., Kartal, E., Dhir, R., & Reid, G. (2021). Delivery of metabolically neuroactive probiotics to the human gut. International Journal of Molecular Sciences, 22(17), 9122. https://doi.org/10.3390/ijms22179122


















